drugset / Trial / NCT00220896

Prevention of Postoperative Delirium With Donepezil

NCT00220896

RandomizedParallel-groupDouble-blindPrevention

Summary

Patients undergoing hip or knee joint replacement at the age of 70 years or above who are cognitively unimpaired will receive donepezil or matching placebo before (over 5-7 days), during and after (over 7 days) surgery. The incidence of delirium will be monitored at 3 days, 7 days, and 49 days following surgery. We hypothesize that the incidence of delirium can be lowered from 20 per cent to 10 per cent by the intervention.

Timeline

Start
2006-01
Primary completion
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule

Indications

No indication recorded.